Clinical Trial Update: Vancomycin Versus Daptomycin for the Treatment of Methicillin Resistant Staphylococcus Aureus (MRSA) Bacteremia [Phase 2]

View source ↗

Summary

Phase 2 randomized trial comparing vancomycin with daptomycin for Staphylococcus aureus bacteremia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Staphylococcus Aureus Bacteremia

Drugs mentioned

• Cubicin (daptomycin)
• Vancomycin (vancomycin)

Snippet

Sponsor: Singapore General Hospital | Conditions: Bacteremia Due to Staphylococcus Aureus | Phase 2 | Status: TERMINATED